Therapeutic and Chemopreventive Effects of Ursodeoxycholic Acid (UDCA): Potential Role in Patients with Barrett’s Esophagus
Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 4
Abstract
Ursodeoxycholic Acid (UDCA) is widely used for the treatment of cholestatic liver diseases. Major mechanisms of this action are protection of cholangiocytes against cytotoxicity of hydrophobic bile acids, stimulation of hepatobiliary secretion, and protection of hepatocytes against bile acid induced apoptosis. UDCA has also been shown to modulate mitochondrial transmembrane potential and prevent increases in mitochondrial Reactive Oxygen Species (ROS) production. Moreover, UDCA has been shown to have a chemopreventive role in mouse models of colon cancer and in patients with primary sclerosing cholangitis and concomitant Inflammatory Bowel Disease (IBD), low dose UDCA lowers the risk of IBD-associated colorectal neoplasia. Our studies suggest that oral UDCA may protect against DNA damage induced by hydrophobic bile acids such as Deoxycholic acid (DCA) in the metaplastic mucosa of patients with Barrett’s esophagus. We have found that DCA induces carcinogenic DNA damage in Barrett’s metaplasia. UDCA which counters the DNA damaging effects of DCA therefore might have a role as a chemopreventive agent in Barrett’s metaplasia. Future clinical studies on the use of UDCA for chemoprevention in patients with Barrett’s esophagus should be considered.
Authors and Affiliations
Xiaofang Huo
Keywords
Related Articles
- EP ID EP555805
- DOI 10.17140/GOJ-1-115
- Views 147
- Downloads 0
Overriding Elements in Colon Cancer Progression: Some Less Known Facts
Colorectal cancer (CRC) is one of the most life threatening disease with escalating mortality and morbidity. Some known causative factors include lifestyle, alcohol etc. but there are other aspects like long standing col...
The Role of Energy Metabolism in Driving Disease Progression in Inflammatory, Hypoxic and Angiogenic Microenvironments
Cellular metabolism plays a crucial role in primed inflammatory, hypoxic and angiogenic microenvironments by supporting disease progression in a range of disease entities. To adapt to fluctuating stress-induced microenvi...
Management of Boerhaave’s Syndrome
Boerhaave’s syndrome or spontaneous oesophageal perforation is characterised by barogenic oesophageal injury. This leads to contamination of the pleural cavity with enteric contents and various degrees of injury.1 The s...
Role of Calcium in Vomiting: Revelations from the Least Shrew Model of Emesis
Cisplatin-like chemotherapeutics cause vomiting via release of multiple neurotransmitters (dopamine, serotonin, or substance P) from the gastrointestinal enterochromaffin cells and/or the brainstem via a Calcium (Ca2+) d...
Percutaneous Endoscopic Gastrostomy: Use and Abuse in Clinical Practice
Nowadays, Percutaneous Endoscopic Gastrostomy (PEG) is considered the method of choice for long-term enteral feeding, and is spreading all over the world because of its effectiveness and easy carrying out. This review en...